Search

Your search keyword '"Fujii, Masashi"' showing total 842 results

Search Constraints

Start Over You searched for: Author "Fujii, Masashi" Remove constraint Author: "Fujii, Masashi" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
842 results on '"Fujii, Masashi"'

Search Results

1. Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial

6. Self-Organization of Diverse Directional Hierarchical Networks in Simple Coupled Maps with Connection Changes

7. A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)

8. Spontaneous organizations of diverse network structures in coupled logistic maps with a delayed connection change

11. Robustness against additional noise in cellular information transmission

12. Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial

13. Development of hydrogen ionic plasma source with superimposed positive-ion beam.

14. Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07

15. Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08)

16. In vivo transomic analyses of glucose-responsive metabolism in skeletal muscle reveal core differences between the healthy and obese states

22. Small-volume effect enables the spine robust, sensitive and efficient information transfer

23. Effect of wearing a surgical mask on short-term pulmonary gas exchange in patients immediately after anaesthesia

24. Trans-omic analysis reveals obesity-associated dysregulation of inter-organ metabolic cycles between the liver and skeletal muscle

26. Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).

29. Single-Cell Information Analysis Reveals That Skeletal Muscles Incorporate Cell-to-Cell Variability as Information Not Noise

32. Genome-wide DNA methylation status to predict the efficacy of modified (m)-FOLFOXIRI plus cetuximab as initial treatment for RAS wild-type metastatic colorectal cancer: A biomarker study of the DEEPER trial (JACCRO CC-13AR).

33. Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08

35. Stochasticity in Ca$^{2+}$ increase in spines enables robust and sensitive information coding

39. Long-term results of a multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (JACCRO CC-04: SHOGUN Trial)

40. Influences of Excluded Volume of Molecules on Signaling Processes on Biomembrane

41. Segregation pattern reorientation of granular mixture on horizontally oscillating tray

42. Saddle-Node Bifurcation to Jammed State for Quasi-One-Dimensional Counter Chemotactic Flow

43. Counter Chemotactic Flow in Quasi-One-Dimensional Path

44. Correlation of multiple endpoints in the first‐line chemotherapy of advanced gastric cancer: Pooled analysis of individual patient data from Japanese Phase III trials

45. Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture

46. 10150-GGE-16 INTRAOPERATIVE INTEGRATED DIAGNOSTIC SYSTEM FOR MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS

47. Characteristics and Treatment Strategies for Basicervical and Transcervical Shear Fractures of the Femoral Neck

48. MO18-4 RAS status in ctDNA and efficacy of FOLFIRI plus ramucirumab in 2nd-line therapy for RAS wild-type mCRC: JACCRO CC-16AR

49. O4-3 An update analysis of the JACCRO CC-16: Ramucirumab plus FOLFIRI for RAS wild-type mCRC refractory to anti-EGFR antibody

50. PS4-3 Survival analysis of m-FOLFOXIRI plus cetuximab vs. bevacizumab in RAS wild-type mCRC: The DEEPER trial (JACCRO CC-13)

Catalog

Books, media, physical & digital resources